Literature DB >> 226558

Interaction between thyroid-stimulating immunoglobulins and thyrotropin receptors in fat cell membranes.

M Kishihara, Y Nakao, Y Baba, S Matsukura, K Kuma, T Fujita.   

Abstract

In the TSH radioreceptor assay to study the interaction between Graves' immunoglobulins (Ig) and TSH receptors in guinea pig fat cell membranes, Graves' Ig were found to inhibit [125I]TSH binding to fat cell membranes in a dose-dependent manner. Scatchard analysis of [125I]TSH displacement curves by Graves' Ig indicated a single population of the binding sites in fat cell membranes, in contrast to two populations of TSH-binding sites in the membranes. Displacement of [125I]TSH bound to fat cell membranes by both Graves' Ig and unlabeled TSH were time and temperature dependent, with similar dissociation curves, suggesting a specific binding of Graves' Ig to the membrane sites related to the TSH receptor in the fat cells. Such Ig are referred to as fat cell-binding Ig, to be distinguished from the thyroid-stimulating Ig (TSI) detected by TSH radioreceptor assay using human thyroid membranes. Both fat cell-binding Ig and TSI were detected in the sera of a great majority of untreated patients with Graves' disease. A significant correlation was found between both values (r = 0.80; n = 19; P less than 0.001). According to these results, TSI might represent an autoantibody to the membranes associated with the TSH receptor of the target tissues without a strict organ specificity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 226558     DOI: 10.1210/jcem-49-5-706

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor.

Authors:  G Wallukat; V Homuth; T Fischer; C Lindschau; B Horstkamp; A Jüpner; E Baur; E Nissen; K Vetter; D Neichel; J W Dudenhausen; H Haller; F C Luft
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

2.  Antineutrophil autoantibodies in Graves' disease. Implications of thyrotropin binding to neutrophils.

Authors:  S A Weitzman; T P Stossel; D C Harmon; G Daniels; F Maloof; E C Ridgway
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

3.  Increased generation of fibrocytes in thyroid-associated ophthalmopathy.

Authors:  Raymond S Douglas; Nikoo F Afifiyan; Catherine J Hwang; Kelvin Chong; Uzma Haider; Patrick Richards; Andrew G Gianoukakis; Terry J Smith
Journal:  J Clin Endocrinol Metab       Date:  2009-11-06       Impact factor: 5.958

4.  Immunoglobulin G inhibitor of thyroid-stimulating antibody is a cause of delay in the onset of neonatal Graves' disease.

Authors:  M Zakarija; J M McKenzie; D S Munro
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

5.  Studies on multiple thyroid cell membrane-directed antibodies in Graves' disease.

Authors:  M Zakarija; A Garcia; J M McKenzie
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.